4 Sep 2018 08:00
Share Buyback
Â
Immunodiagnostic Systems Holdings PLC
4 September 2018
Â
Immunodiagnostic Systems Holdings plc
Completion of Share Buyback
Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, today announces that further to the proposed share buyback announcement on 30 August 2018 the Company has acquired 600,000 ordinary shares of 0.2p ("Ordinary Shares") at 220 pence per Ordinary Share. All Ordinary Shares purchased under the share buyback will be held in Treasury.
Total Voting Rights
The Company's issued share capital comprises 29,450,175 Ordinary Shares. Of these 666,078 are held in Treasury. The total voting rights of the Company are 28,784,097 Ordinary Shares and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 5190660 |
Jaap Stuut, Chief Executive Officer | |
Paul Martin, Group Finance Director | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Oliver Jackson | |
Sohail Akbar (ECM) |
Â